Lyell Immunopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 331 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 201-225 of 331 matching filings.

Per page
25
Current page
9
4

FORM 4 SUBMISSION

Filing date
17 Aug 2023
Reporting date
15 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
15 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Aug 2023
Reporting date
10 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Jul 2023
Reporting date
01 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-40502

144 filing

Filing date
17 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Jun 2023
Reporting date
16 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-40502

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .